Studies at the University of Pittsburgh found that the brains of patients with insomnia were overactive. Pitt had a patent for a technique to reduce brain metabolic activity using cooling, and Dr. Eric Nofzinger saw the potential. The burgeoning business of sleep is awakening. Nationally, the global sleep services market is expected to reach $8.4…
Cerêve Raises $38 Million to Fuel Launch of Insomnia Device in New Financing Led by KKR Investment Will Fund Launch of FDA-cleared Device to Safely Treat Insomnia OAKMONT, Pa.–(BUSINESS WIRE)–Jan. 5, 2017– Cerêve Inc., a privately-held health care company preparing to launch its FDA-cleared insomnia device, announced today the closing of a $38 million Series B round…
FDA Clears Sleep Device for Insomnia System cools hyperactive frontal cortex The FDA has granted commercial clearance for the Cerêve Sleep System, a prescription device that reduces latency to stage-1 and stage-2 sleep for people with insomnia. Functional brain-imaging studies have shown that the frontal cortex, or executive brain, remains active in people with insomnia…